-
CTXR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Citius Pharmaceuticals (CTXR)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 12.56 mm | 12.56 mm | 12.56 mm | 12.56 mm | 12.56 mm | 12.56 mm |
Cash burn (monthly) | 2.60 mm | 1.38 mm | 3.66 mm | 3.26 mm | 2.60 mm | 2.53 mm |
Cash used (since last report) | 22.73 mm | 12.05 mm | 32.02 mm | 28.54 mm | 22.73 mm | 22.11 mm |
Cash remaining | -10.17 mm | 514.39 k | -19.46 mm | -15.98 mm | -10.17 mm | -9.55 mm |
Runway (months of cash) | -3.9 | 0.4 | -5.3 | -4.9 | -3.9 | -3.8 |
13F holders | Current |
---|---|
Total holders | 70 |
Opened positions | 22 |
Closed positions | 20 |
Increased positions | 14 |
Reduced positions | 17 |
13F shares | Current |
---|---|
Total value | 17.62 bn |
Total shares | 30.34 mm |
Total puts | 0.00 |
Total calls | 24.70 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Armistice Capital | 10.16 mm | $5.93 bn |
Vanguard | 6.33 mm | $3.69 bn |
Millennium Management | 2.05 mm | $1.20 bn |
BLK BlackRock | 1.81 mm | $1.05 bn |
Geode Capital Management | 1.65 mm | $961.17 mm |
GS The Goldman Sachs Group, Inc. | 1.19 mm | $692.60 mm |
NTRS Northern Trust | 1.06 mm | $615.83 mm |
Advisor | 932.33 k | $544.07 mm |
Susquehanna International | 640.54 k | $373.88 mm |
STT State Street | 581.80 k | $339.60 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Nov 24 | Jaime Bartushak | Stock Option (Right to Purchase Common Stock) Common Stock | Grant | Acquire A | No | No | 0.38 | 350,000 | 133.00 k | 350,000 |
7 Nov 24 | Mazur Leonard L | Stock Option (Right to Purchase Common Stock) Common Stock | Grant | Acquire A | No | No | 0.38 | 600,000 | 228.00 k | 600,000 |
7 Nov 24 | Webb Carol | Stock Option (Right to Purchase Common Stock) Common Stock | Grant | Acquire A | No | No | 0.38 | 125,000 | 47.50 k | 125,000 |
7 Nov 24 | Robert Joseph Smith | Stock Option (Right to Purchase Common Stock) Common Stock | Grant | Acquire A | No | No | 0.38 | 125,000 | 47.50 k | 125,000 |
7 Nov 24 | Myron Czuczman | Stock Option (Right to Purchase Common Stock) Common Stock | Grant | Acquire A | No | No | 0.38 | 300,000 | 114.00 k | 300,000 |